Jinhuan Yang

Jinhuan Yang

Auto-generated profile, based on publicly available information

Jinhuan Yang

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, P.R. China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2022 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
JYJinhuan Yang
Jinhuan Yang
KCKaiwen Chen
Kaiwen Chen
CZChongming Zheng
Chongming Zheng
KCKaiyu Chen
Kaiyu Chen
JLJian Lin
Jian Lin
GCGang Chen
Gang Chen
Background: Previous studies have indicated that sarcopenia is associated with poor post‐operative outcomes in liver cancer patients, but the studies are limited by confounding from mixed diseases, retrospective data, and non‐standardized measurement methods. At present, there is no research with both muscle mass and strength as predictors for hepatocellular carcinoma (HCC) outcomes. We studied the impact of sarcopenia on post‐operative outcomes in HCC patients in a cohort study designed according to the European Working Group on Sarcopenia in Older People standards.Methods: A total of 781 consecutive patients admitted to our centre were registered from May 2020 to August 2021. All participants submitted questionnaires and underwent handgrip strength, chair stand test, physical performance, and computed tomographic evaluation. Then, they were divided into three groups according to muscle mass and strength: Group A (reduced muscle mass and strength), Group B (reduced muscle strength or reduced muscle mass), and Group C (normal muscle mass and strength). The baseline data and post‐operative outcomes were compared and analysed. The primary outcome variable in this study was the presence of a major post‐operative complication, and the secondary outcome was the 90‐day re‐admission rate.Results: A total of 155 patients [median age, 60.00 (IQR, 51.00–66.00) years; 20 females (12.90%)] were included after strict exclusion. The mean (SD) BMI was 23.37 ± 0.23 kg/m2. The mean (SD) SMI of all participants was 47.05 ± 0.79 cm2/m2, and the mean (SD) handgrip strength was 32.84 ± 0.69 kg. Among them, 77 (49.68%) patients underwent laparoscopic hepatectomy, and 73 (47.10%) patients received major hepatectomy. Regarding the post‐operative results, Group A had a higher rate of major complications [40.91% (9 of 22) vs. 11.94% (8 of 67) in Group B and 6.06 (4 of 66) in Group C; P = 0.001], higher rate of blood transfusion (77.27% vs. 46.27% in Group B and 42.42% in Group C; P = 0.015), higher hospitalization expenses (P = 0.001), and longer hospital stay (P < 0.001). There was no difference in 90‐day re‐admission rates among the three groups. Sarcopenia (hazard ratio, 10.735; 95% CI, 2.547–45.244; P = 0.001) and open surgery (hazard ratio, 4.528; 95% CI, 1.425–14.387; P = 0.010) were independent risk factors associated with major complications.Conclusions: Sarcopenia is associated with adverse outcomes after liver resection for HCC. It should be evaluated upon admission to classify high‐risk patients and reduce the risk of major complications.

14 February 2023 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
ZBZhiyuan Bo
Zhiyuan Bo
BCBo Chen
Bo Chen
ZZZhengxiao Zhao
Zhengxiao Zhao
QHQikuan He
Qikuan He
YMYicheng Mao
Yicheng Mao
GCGang Chen
Gang Chen
Purpose: We aimed to construct machine learning (ML) radiomics models to predict response to lenvatinib monotherapy for unresectable hepatocellular carcinoma (HCC). Experimental Design: Patients with HCC receiving lenvatinib monotherapy at three institutions were retrospectively identified and assigned to training and external validation cohorts. Tumor response after initiation of lenvatinib was evaluated. Radiomics features were extracted from contrast-enhanced CT images. The K-means clustering algorithm was used to distinguish radiomics-based subtypes. Ten ML radiomics models were constructed and internally validated by 10-fold cross-validation. These models were subsequently verified in an external validation cohort. Results: A total of 109 patients were identified for analysis, namely, 74 in the training cohort and 35 in the external validation cohort. Thirty-two patients showed partial response, 33 showed stable disease, and 44 showed progressive disease. The overall response rate (ORR) was 29.4%, and the disease control rate was 59.6%. A total of 224 radiomics features were extracted, and 25 significant features were identified for further analysis. Two distant radiomics-based subtypes were identified by K-means clustering, and subtype 1 was associated with a higher ORR and longer progression-free survival (PFS). Among the 10 ML algorithms, AutoGluon displayed the highest predictive performance (AUC = 0.97), which was relatively stable in the validation cohort (AUC = 0.93). Kaplan–Meier analysis showed that responders had a better overall survival [HR = 0.21; 95% confidence interval (CI): 0.12–0.36; P < 0.001] and PFS (HR = 0.14; 95% CI: 0.09–0.22; P < 0.001) than nonresponders. Conclusions: Valuable ML radiomics models were constructed, with favorable performance in predicting the response to lenvatinib monotherapy for unresectable HCC.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
DMDelin Ma
Delin Ma
GDGang Du
Gang Du
JYJinhuan Yang
Jinhuan Yang
JSJianping Song
Jianping Song
HMHuan Ma
Huan Ma
BJBin Jin
Bin Jin
Background. The technical challenge of pancreatojejunostomy (PJ) is the greatest barrier for surgeons to complete pancreatoduodenectomy (PD). The authors present an easy‐to‐master PJ anastomosis technique with limited technical requirements. This technique uses two layers of sutures and double purse‐string sutures to complete the entire anastomosis. This anastomosis technique has achieved good results in laparoscopic surgery (LS) and small size main pancreatic duct (MPD). Methods. From February 2015 to August 2020, 63 patients who met the surgical indications underwent a modified double purse‐string continuous suture pancreaticojejunostomy technique in our center. We collected patient demographic characteristics and perioperative outcomes and analyzed these data. Results. A total of 63 patients underwent PD using our new anastomosis technique. Thirty‐eight patients underwent LS, and 26 patients had a small MPD (<3 mm). The median operative time (OT) was 270 min, and the median estimated blood loss (EBL) was 200 ml. Ten patients had grade B postoperative pancreatic fistula (POPF), while no patients had grade C POPF. No 90‐day mortality was observed. There were significant differences in the OT and postoperative hospital stay (PHS) among groups with different surgical procedures, while there were no significant differences among groups with different MPD sizes. Neither the surgical procedure nor the MPD size affected early postoperative complications. Conclusion. This new technique can not only reduce the incidence of POPF but also is reliable for LS and surgeries with small size MPD. Therefore, this technique is worthy of clinical promotion and application in the future.

1 April 2023
Verified
Other
Open access
ZBZhiyuan Bo
Zhiyuan Bo
BCBo Chen
Bo Chen
ZZZhengxiao Zhao
Zhengxiao Zhao
QHQikuan He
Qikuan He
YMYicheng Mao
Yicheng Mao
GCGang Chen
Gang Chen
Essential scripts for each model and the specific parameters of the models.

1 April 2023
Verified
Other
Open access
ZBZhiyuan Bo
Zhiyuan Bo
BCBo Chen
Bo Chen
ZZZhengxiao Zhao
Zhengxiao Zhao
QHQikuan He
Qikuan He
YMYicheng Mao
Yicheng Mao
GCGang Chen
Gang Chen
Baseline characteristics between patients with unresectable HCC treated with lenvatinib in the training and external validation cohort.